van Dijk VB, Grobbee DE, de Vries MC, Groenwold RHH, van der Graaf R, Schuit, E. A Systematic Breakdown of the Levels of Evidence 1 Supporting the European Society of Cardiology Guidelines. Eur J Prev Cardiol. 2019; 26: 1944–1952.
2.
VaucherJMarques-VidalPWaeberG, et al.Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management. Eur J Prev Cardiol2018; 25: 1111–1113.
3.
TricociPAllenJMKramerJM, et al.Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA2009; 301: 831–841.
4.
FanaroffACCaliffRMWindeckerS, et al.Levels of evidence supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008–2018. JAMA2019; 321: 1069–1080.
5.
VigoritoCAbreuAAmbrosettiM, et al.Frailty and cardiac rehabilitation: A call to action from the EAPC cardiac rehabilitation section. Eur J Prev Cardiol2017; 24: 577–590.
6.
PiepoliMFHoesAWAgewallS, et al.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
